DUOCLAV TABLETS 625

Indications

• Bacterial respiratory tract infections
• Urinary tract infections
• Skin and soft tissue infections
• Otitis media
• Gastrointestinal infections
• Helicobacter pylori eradication

Dosage

Children: Refer to the BNF for Children for specific dosing information, as it is determined based on the child's age and weight.

Adults: Refer to the appropriate clinical guidelines for specific dosing information, as it varies based on the infection being treated.

Mechanism of action

Amoxicillin exerts its antibacterial effect by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding inhibits the transpeptidation enzyme, which is essential for cross-linking peptidoglycan layers. The inhibition of cell wall synthesis ultimately leads to cell lysis and death, particularly in actively dividing bacteria.

Pharmacodynamics

Amoxicillin is effective against a wide range of Gram-positive and some Gram-negative bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, and Haemophilus influenzae. The drug exhibits time-dependent killing, meaning that its efficacy is related to the time the drug concentration remains above the minimum inhibitory concentration (MIC) for the target organism. Resistance to amoxicillin can occur through the production of beta-lactamases, which hydrolyze the antibiotic.

Pharmacokinetics

Amoxicillin is well-absorbed from the gastrointestinal tract, with bioavailability around 75-90%. It reaches peak plasma concentrations approximately 1-2 hours after oral administration. The drug is primarily eliminated via the kidneys, with 60-70% of a dose being excreted unchanged in the urine. Its half-life is approximately 1-1.5 hours in individuals with normal renal function, and dosage adjustments may be necessary in patients with renal impairment.

Contra-indications

• Hypersensitivity to penicillins
• History of severe allergic reactions to beta-lactam antibiotics
• Mononucleosis (increased risk of rash)

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Rash
• Allergic reactions (e.g., anaphylaxis)
• Hepatic dysfunction
• Superinfection (e.g., Clostridium difficile-associated diarrhea)

Interactions

• Probenecid (increased amoxicillin levels)
• Oral contraceptives (reduced efficacy)
• Methotrexate (increased toxicity)
• Anticoagulants (increased risk of bleeding)

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of superinfection
• Caution in patients with a history of gastrointestinal disease
• Discontinue if severe allergic reaction occurs

Pregnancy

Amoxicillin is generally considered safe during pregnancy. However, it should only be used if clearly needed, with careful consideration of the benefits and risks.

Breast-feeding

Amoxicillin is excreted in breast milk in small amounts. It is generally considered safe for use during breastfeeding, but monitoring for possible effects on the infant is advised.

Storage

Store in a cool, dry place away from light. Reconstituted solutions should be stored in a refrigerator and used within the specified time frame.

Formulations

• Tablets
• Capsules
• Oral suspension
• Injection

Pregnancy

Clovlava should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult healthcare providers for guidance.

Breast-feeding

Clovlava is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Parkinson's disease
• Extrapyramidal symptoms due to antipsychotic drugs
• Dystonia
• Acute dystonic reactions

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines.

Adults: Refer to the BNF for specific dosing guidelines.

Mechanism of action

Trihexyphenidyl works by blocking the action of acetylcholine on muscarinic receptors in the central nervous system. This antagonistic action helps to restore the balance between acetylcholine and dopamine, which is often disrupted in Parkinson's disease and in patients receiving antipsychotic therapy.

Pharmacodynamics

The therapeutic effects of trihexyphenidyl include reducing rigidity and tremors, as well as improving overall motor function in patients with Parkinson's disease. It also has effects on cognitive functions and can influence mood. The onset of action is typically within hours of administration, with peak effects occurring several hours later.

Pharmacokinetics

Trihexyphenidyl is well absorbed from the gastrointestinal tract, with peak plasma concentrations achieved within 1 to 2 hours after oral administration. It undergoes extensive hepatic metabolism and has a half-life of approximately 3 to 8 hours. The drug is primarily excreted in the urine as metabolites. Its pharmacokinetics can be affected by age, liver function, and concurrent medications.

Pregnancy

Safety during pregnancy has not been established. Use only if potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.